Akt1 deletion prevents lung tumorigenesis by mutant K-ras

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• K-ras mutations are linked to smoking-induced lung cancer and poor prognosis.
• K-ras mutations activate phosphoinoside-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) pathways.
• The specific roles of Akt isoforms (Akt1, Akt2, Akt3) in this pathway remain unclear.

Purpose of the Study:

• To investigate the distinct roles of Akt isoforms in K-ras-driven lung tumorigenesis.
• To determine which Akt isoform is critical for lung tumor initiation and progression.

Main Methods:

• Utilized mouse models of lung cancer (tobacco carcinogen-induced and genetic).
• Generated knockout mice lacking specific Akt isoforms (Akt1, Akt2, or Akt3).
• Assessed tumor development, progression, and signaling pathways in these models.
• Examined K-ras-mutant lung cancer cells and fibroblasts lacking Akt1.

Main Results:

• Deletion of Akt1 prevented lung tumor initiation and progression in both mouse models.
• Akt1 deficiency rendered fibroblasts resistant to K-ras-mediated transformation and EGF stimulation.
• Deletion of Akt3 increased tumor multiplicity and size in specific models.
• Human lung cancer cells with diminished Akt1 showed impaired in vivo growth.

Conclusions:

• Akt1 is the primary Akt isoform activated by mutant K-ras in lung tumors.
• Akt1 plays a critical role in K-ras-driven lung tumorigenesis and progression.
• Akt3 may have a tumor-suppressive role, potentially opposing Akt1.
• Targeting Akt1 specifically could be a viable therapeutic strategy for K-ras-mutant lung cancer.